OXLCL Oxford Lane Capital Corp 675 Notes due 2031 posts Q4 2025 EPS miss yet shares climb modestly in todays trading Cohen LDP Stock Market Opportunity Steady Climb 20260418 Is GEE Group JOB stock resilient to market changes Q4 2025 EPS Misses Estimates Oil Prices Decline as USIran Talks Show Signs of Progress OpenAI Sets Sights on IPO as AI Competition Heats Up Confidential Filing Reportedly Imminent Natural Gas Prices Slide Amid Increased APAC LNG Flows and Storage Competition Tempus AI Launches ArteraAI Prostate Test Pioneering Digital Pathology Algorithm for Prostate Cancer Wall Street Sentiment on Lam Research A Balanced View on the Semiconductor Equipment Giant Worker Confidence Plunges to Record Low Amid Rising AI Job Displacement Fears Global Survey Finds ASNS Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue Disclosure RILYN Q1 2024 Earnings Negative EPS and Bond Price Movement Amid Operational Challenges HA Sustainable Infrastructure Capital Inc HASI Q1 2026 Earnings Strong EPS Beat Mitigates Revenue Uncertainty Stock Holds Steady ESS Q1 2026 Earnings EPS Beat Lifts Shares Amid Steady Apartment Demand LXP Industrial Trust Q1 2026 Earnings EPS Misses Estimates Amid Resilient Operational Trends IP Q1 2026 Earnings Industrial Packaging Giant Beats EPS Estimates Amid Cost Disciplines Callan JMB Inc CJMB Edges Higher as Consolidation Near Support Continues Jefferson Capital JCAP Edges Lower Amid Mild Selling Pressure Primo Brands Corporation PRMB Holds Near 2453 as Support and Resistance Levels Tighten Hennessy Capital Investment Corp VIII Units HCICU Hold Steady at 1004 as Market Awaits Business Combination Progress Fermi Inc FRMI Posts Modest Gains as Stock Holds Above Key Support ProfitTaking Strategy Trimming a Stock That Surged 80 Since April Initiation PodcastOne Inc PODC Q1 2026 Earnings Profitability Surprise Drives 9 Stock Rally Atlanticus Holdings Senior Notes ATLCL Trade Flat at 25 Amid Balanced Credit Outlook ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline Ashland Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures ImageneBio IMA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline TRIN Q1 2026 Earnings EPS Beats Estimates Stock Edge Higher ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss VABK Q1 2026 Earnings Steady Profitability Amid Stable Banking Operations